4DMedical secures $30.2M through options underwriting to boost CT:VQ commercialisation
4DMedical (ASX:4DX) has secured $30.2 million in funding by entering an underwriting agreement with Bell Potter Securities, ensuring the full exercise of its 4DXO listed options.
Under the agreement, any unexercised options at expiry will be subscribed by the underwriter, guaranteeing the total funding amount.











-640x359.jpg&w=3840&q=75)





